CLINICAL TRIALS & RESEARCH
News

Informed Consent Subgroup Offers Comments to EMA

MRCT Center at Harvard Informed Consent Subgroup has submitted comments on EMA Draft Policy 0070. This subgroup is part of the second phase of MRCT’s efforts related to Clinical Trial Data Sharing and Transparency, called “Implementation and Solutions”.

Members of academia, industry, and non-profits contributed to this effort. Please find the group’s final comments  here.